9-tert-Butyldoxycycline
9-tert-Butyldoxycycline exhibits immunomodulatory activity, alters the polarization states polymorphonuclear neutrophils, and ameliorates the inflammatory response in ischemia-reperfusion injury model. 9-tert-Butyldoxycycline is the ligand for ‘Tet-On’ switch system[1].
Product Specifications
CAS Number
233585-94-9
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Smiles
O[C@]12[C@]([C@H]([C@@]3([H])C(C(C4=C(O)C(C(C)(C)C)=CC=C4[C@@H]3C)=O)=C2O)O)([H])[C@@H](C(O)=C(C1=O)C(N)=O)N(C)C
Molecular Formula
C26H32N2O8
Molecular Weight
500.54
References & Citations
[1]Mai N, et al., Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injury. Exp Mol Pathol. 2021 Feb;118:104601.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC473340-500 1x 500 µL
CD11b / MAC-1 (Microglial Marker) (ITGAM/3340), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
